Eveotec, Indivumed partner on novel lung cancer therapies
Evotec and Indivumed announced on January 23 a partnership to collaborate on drug discovery and development of novel therapies for non-small cell lung cancer. The goal of the collaboration is to provide highly effective precision medicine treatments for patients.
HighRes, Novo Nordisk work on robotic drug discovery
Life science robotics company HighRes Biosolutions and global healthcare company Novo Nordisk plan to design a robotic platform for high-throughput biologics engineering and characterization of potential drug discovery candidates.
Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint venture is owned equally by three partners: Bio-Techne, Fresenius Kabi, and Wilson Wolf.
Key CRISPR patent revoked in Europe
An important patent on CRISPR technology held by the Broad Institute has been revoked by the European Patent Office.
LabCorp adopts Thermo Fisher NGS for companion diagnostics
LabCorp announced on January 14 that it will adopt Thermo Fisher Scientific's Ion Torrent Genexus next-generation sequencing (NGS) system and Oncomine precision assay for use in research and development of companion diagnostics and precision medicine applications.
Evotec, Bayer partner for drug discovery in women's health
Evotec and Bayer announced on January 9 the expansion of their partnership in women's health with a new five-year, multitarget collaboration with participation from Celmatix to develop multiple clinical candidates for the treatment of polycystic ovary syndrome.
Merck announces new drug development collaboration
Merck announced on January 6 that it has entered into an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical and Astex Pharmaceuticals (UK).
Software improves compatibility and efficiency in chromatography
On January 2, Thermo Fisher Scientific and Agilent Technologies announced their continued agreement to the industry-wide Instrument Control Exchange Program (ICEP).
MilliporeSigma licenses CRISPR tech to Promega
MilliporeSigma announced on December 19 that it has signed a license agreement providing Promega Corp., access to MilliporeSigma's foundational CRISPR intellectual property.
GE & Advanced Solutions announce strategic collaboration
On Sunday, December 8, GE Healthcare Life Sciences and Advanced Solutions Life Sciences announced a strategic partnership for their integrated IN Cell Analyzer and BioAssemblyBot systems.